La vendita allo scoperto per CO2 Energy Transition Corp. - Right dà agli investitori un'idea del grado in cui gli investitori stanno scommettendo sul declino delle azioni di CO2 Energy Transition Corp. - Right. I dati relativi alle vendite allo scoperto vengono aggiornati ogni due settimane.

CO2 Energy Transition Corp. - Right (NASDAQ:NOEMR) Azioni, Report sulle vendite allo scoperto

CO2 Energy Transition Corp. - Right

WIIM

ASST

Asset Entities shares are trading higher after the company announced it entered into a merger agreement with Strive Asset Management.

Saratoga Investment shares are trading lower after the company reported worse-than-expected Q4 financial results.

UBS analyst Jon Windham maintains Array Technologies (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/ARRY#NASDAQ">ARRY</a>) with a Buy and raises the price target from $7 to $8.5.

News

Price Target

Analyst Ratings

ARRY

UBS Maintains Buy on Array Technologies, Raises Price Target to $8.5

KIND

Nextdoor Holdings shares are trading lower. The company reported Q1 financial results.

RBC Capital analyst Brad Heffern maintains UDR (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/UDR#NYSE">UDR</a>) with a Sector Perform and raises the price target from $43 to $44.

RBC Capital Maintains Sector Perform on UDR, Raises Price Target to $44

NL Industries shares are trading lower after the company reported worse-than-expected Q1 EPS results.

Krispy Kreme, Inc. (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/DNUT#NASDAQ">DNUT</a>) shares are trading lower on Thursday after the company reported adjusted earnings per share of a five-cent loss in the first quarter, which <a href="https://www.benzinga.com/pressreleases/25/05/b45280346/krispy-kreme-reports-first-quarter-2025-financial-results" target="_blank" rel="noreferrer noopener">is in line with analyst estimates.</a>
Quarterly sales of $375.18 million (down 15.3% year over year) missed the Street view of $384.376 million. Organic revenue declined 1% to $374.7 million amid consumer softness, leading to a decline in doughnut shop transaction volume.
Revenues declined primarily due to the $64.3 million reduction associated with the divestiture of a majority stake in Insomnia Cookies in the third quarter of fiscal 2024.
Also Read: <a href="https://www.benzinga.com/analyst-ratings/analyst-color/25/03/44423826/is-tariff-an-issue-for-restaurant-sector-j-p-morgan-highlights-winners-losers" target="_blank" rel="noreferrer noopener">Is Tariff An Issue For Restaurant Sector? J.P. Morgan Highlights Winners &amp; Losers</a>
The company reported adjusted EBITDA of $24 million, down 58.8% year over year. Adjusted EBITDA margin contracted 670 basis points on a year-over-year basis to 6.4%.
During the first quarter of 2025, the company invested $25.9 million, or 6.9% of net revenue, in capital expenditures.
As previously announced, the company continues to evaluate opportunities to franchise certain international markets, including Australia and New Zealand, Japan, Mexico, and the U.K. and Ireland.
Krispy Kreme has also decided to no longer pay quarterly cash dividends to holders of the company&#8217;s common stock.
Outlook: Krispy Kreme expects second-quarter sales to range between $370 million and $385 million, below the estimated $393.85 million.
Given the macroeconomic softness and the uncertainty around the McDonald&#8217;s deployment schedule, Krispy Kreme is withdrawing its prior full year outlook and not updating it at this time.
As of March 30, Krispy Kreme doughnuts are now available in more than 2,400 McDonald&#8217;s restaurants.&nbsp;
&#8220;The company is reassessing the deployment schedule together with McDonald&#8217;s while it works to achieve a profitable business model for all parties and does not expect to launch in any additional restaurants in the second quarter of 2025,&#8221; it said in a press release.
Price Action: At the last check on Thursday,&nbsp;DNUT shares are trading lower by 27.4% to $3.142.
Read Next:
<ul>
<li><a href="https://www.benzinga.com/economics/macro-economic-events/25/05/45285797/forget-rate-cuts-this-year-bank-of-america-warns-after-powells-hawkish-tone" target="_blank" rel="noreferrer noopener">Forget Rate Cuts This Year, Bank Of America Warns After Powell&#8217;s Hawkish Tone</a></li>
</ul>
Image by Morumotto via Shutterstock

Earnings

Equities

Guidance

Dividends

Markets

Movers

General

DNUT

Krispy Kreme Stock Falls After Uncertainty Warning, Dividend Halt

UBS analyst Thomas Wadewitz maintains Delta Air Lines (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/DAL#NYSE">DAL</a>) with a Neutral and raises the price target from $42 to $46.

UBS Maintains Neutral on Delta Air Lines, Raises Price Target to $46

GMRE

Global Medical REIT shares are trading lower after the company reported mixed Q1 financial results. Also, Baird lowered its price target on the stock from $10 to $9.

UBS analyst John Hodulik maintains AppLovin (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/APP#NASDAQ">APP</a>) with a Buy and raises the price target from $450 to $475.

UBS Maintains Buy on AppLovin, Raises Price Target to $475

RBC Capital analyst Maurice Choy maintains TransAlta (TSX:<a class="ticker" href="https://www.benzinga.com/stock/TA#TSX">TA</a>) with a Outperform and lowers the price target from C$23 to C$20.

TSX:TA

RBC Capital Maintains Outperform on TransAlta, Lowers Price Target to C$20

CMRE

Costamare shares are trading higher after the company reported better-than-expected Q1 financial results.

Johnson Controls shares are trading higher after the company reported better-than-expected Q2 financial results and raised its FY2025 earnings guidance.

UBS analyst Jeff Hickey maintains DigitalOcean Holdings (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/DOCN#NYSE">DOCN</a>) with a Neutral and lowers the price target from $44 to $32.

DOCN

UBS Maintains Neutral on DigitalOcean Holdings, Lowers Price Target to $32

RBC Capital analyst Maurice Choy maintains TransAlta (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/TAC#NYSE">TAC</a>) with a Outperform and lowers the price target from $23 to $20.

RBC Capital Maintains Outperform on TransAlta, Lowers Price Target to $20

Dine Brands Global shares are trading higher after Barclays raised its price target on the stock from $21 to $24.

UBS analyst Roger Boyd maintains Fortinet (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/FTNT#NASDAQ">FTNT</a>) with a Neutral and lowers the price target from $115 to $105.

FTNT

UBS Maintains Neutral on Fortinet, Lowers Price Target to $105

RBC Capital analyst Arun Viswanathan maintains Chemours (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/CC#NYSE">CC</a>) with a Outperform and lowers the price target from $17 to $14.

RBC Capital Maintains Outperform on Chemours, Lowers Price Target to $14

Capital Allocation and Dividend Policy
As previously announced, the Company continues to evaluate opportunities to refranchise certain international markets including Australia and New Zealand, Japan, Mexico, and the U.K. and Ireland.
Following a review of the Company's capital allocation strategy and investments available to fuel our growth, the Company has made the decision to no longer pay quarterly cash dividends to holders of the Company's common stock. This decision provides greater financial flexibility, enabling debt paydown and a focus on profitable, high return growth.

Krispy Kreme Halts Quarterly Dividend Payments

UBS analyst Lu Li maintains Veracyte (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/VCYT#NASDAQ">VCYT</a>) with a Buy and lowers the price target from $49 to $42.

Comments

CO2 Energy Transition Corp. - Right

Vendite allo scoperto

CO2 Energy Transition Corp. - Right (NASDAQ:NOEMR) Azioni, Report sulle vendite allo scoperto

Notizie

PARTNER/COLLABORATORE

BENZINGA NEL MONDO